Royal Bank of Canada’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Royal Bank of Canada’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$607K	Sell	11,591 -678	-6%	-$34.5K	﹤0.01%	3990
2025 Q4	$628K	Buy	12,269 +330	+3%	+$15.3K	﹤0.01%	3998
2025 Q3	$464K	Buy	11,939 +1,450	+14%	+$49.8K	﹤0.01%	4544
2025 Q2	$315K	Sell	10,489 -79	-0.7%	-$2.26K	﹤0.01%	4813
2025 Q1	$302K	Sell	10,568 -1,120	-10%	-$35.4K	﹤0.01%	4387
2024 Q4	$386K	Buy	11,688 +636	+6%	+$24K	﹤0.01%	4281
2024 Q3	$413K	Sell	11,052 -1,500	-12%	-$54.7K	﹤0.01%	4244
2024 Q2	$421K	Buy	12,552 +1,598	+15%	+$53.5K	﹤0.01%	4153
2024 Q1	$391K	Sell	10,954 -4,562	-29%	-$158K	﹤0.01%	4145
2023 Q4	$510K	Sell	15,516 -13,290	-46%	-$357K	﹤0.01%	4249
2023 Q3	$783K	Buy	28,806 +7,214	+33%	+$217K	﹤0.01%	3649
2023 Q2	$681K	Buy	21,592 +1,556	+8%	+$48.3K	﹤0.01%	3704
2023 Q1	$544K	Sell	20,036 -44,766	-69%	-$1.35M	﹤0.01%	3809
2022 Q4	$1.97M	Buy	64,802 +22,434	+53%	+$675K	﹤0.01%	2914
2022 Q3	$1.28M	Sell	42,368 -1,617	-4%	-$51.1K	﹤0.01%	3233
2022 Q2	$1.22M	Buy	43,985 +2,111	+5%	+$60.2K	﹤0.01%	3324
2022 Q1	$1.41M	Buy	41,874 +5,854	+16%	+$203K	﹤0.01%	3363
2021 Q4	$1.52M	Sell	36,020 -20,669	-36%	-$921K	﹤0.01%	3412
2021 Q3	$2.58M	Buy	56,689 +24,937	+79%	+$1.14M	﹤0.01%	2861
2021 Q2	$1.55M	Sell	31,752 -32,575	-51%	-$1.56M	﹤0.01%	3280
2021 Q1	$3.23M	Buy	64,327 +28,934	+82%	+$1.6M	﹤0.01%	2589
2020 Q4	$1.81M	Sell	35,393 -39,348	-53%	-$1.87M	﹤0.01%	3004
2020 Q3	$3.08M	Buy	74,741 +7,946	+12%	+$328K	﹤0.01%	2343
2020 Q2	$2.79M	Buy	66,795 +6,889	+11%	+$272K	﹤0.01%	2362
2020 Q1	$1.9M	Buy	59,906 +36,535	+156%	+$1.4M	﹤0.01%	2517
2019 Q4	$989K	Sell	23,371 -2,787	-11%	-$103K	﹤0.01%	3453
2019 Q3	$826K	Buy	26,158 +1,825	+8%	+$64.2K	﹤0.01%	3498
2019 Q2	$879K	Sell	24,333 -1,124	-4%	-$38.8K	﹤0.01%	3410
2019 Q1	$921K	Sell	25,457 -5,765	-18%	-$193K	﹤0.01%	3261
2018 Q4	$879K	Buy	31,222 +3,117	+11%	+$103K	﹤0.01%	3267
2018 Q3	$1.11M	Buy	28,105 +2,505	+10%	+$95K	﹤0.01%	3272
2018 Q2	$954K	Sell	25,600 -10,800	-30%	-$392K	﹤0.01%	3267
2018 Q1	$1.25M	Buy	36,400 +15,619	+75%	+$548K	﹤0.01%	3011
2017 Q4	$681K	Sell	20,781 -3,697	-15%	-$116K	﹤0.01%	3550
2017 Q3	$763K	Buy	24,478 +11,137	+83%	+$327K	﹤0.01%	3459
2017 Q2	$372K	Sell	13,341 -6,459	-33%	-$168K	﹤0.01%	3896
2017 Q1	$510K	Sell	19,800 -2,505	-11%	-$62.3K	﹤0.01%	3621
2016 Q4	$511K	Buy	22,305 +7,697	+53%	+$184K	﹤0.01%	3723
2016 Q3	$381K	Buy	14,608 +8,071	+123%	+$201K	﹤0.01%	3937
2016 Q2	$148K	Buy	6,537 +1,524	+30%	+$36.2K	﹤0.01%	4587
2016 Q1	$110K	Buy	5,013 +1,238	+33%	+$28.3K	﹤0.01%	4708
2015 Q4	$120K	Buy	3,775 +20	+0.5%	+$613	﹤0.01%	4830
2015 Q3	$105K	Buy	3,755 +1,845	+97%	+$64.4K	﹤0.01%	4754
2015 Q2	$68K	Sell	1,910 -13,820	-88%	-$451K	﹤0.01%	5054
2015 Q1	$470K	Buy	+15,730	New	+$442K	﹤0.01%	3568

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Royal Bank of Canada's SBIO Position: Q1 2026 in Review

Royal Bank of Canada reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 5.5% in Q1 2026, selling an estimated $34.5K and leaving 11,591 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #3990.

Royal Bank of Canada first reported a position in SBIO in Q1 2015 and has held it in 45 quarters since. The position peaked at $3.23M in Q1 2021. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Royal Bank of Canada held 11,591 shares of ALPS Medical Breakthroughs ETF worth $607K as of Q1 2026.
Royal Bank of Canada sold 678 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $34.5K.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3990 holding.
Royal Bank of Canada first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and has held it in 45 quarters since.
Royal Bank of Canada's ALPS Medical Breakthroughs ETF position peaked at $3.23M in Q1 2021.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.